This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "NEOPRISM-CRC Trial - Neoadjuvant Pembro Stratified to TMB for High-Risk Stage 2 or 3 dMMR/MSI-High CRC"

71 views
June 12, 2024
0 Comments
Login to view comments. Click here to Login